Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Temtokibart by Leo Pharma for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Temtokibart is under clinical development by Leo Pharma and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...